The LIMK1-cofilin-actin pathway presents a complex and dynamic role in the pathogenesis of AD, where it appears to mediate both neuroprotective and neurodegenerative mechanisms across different stages of disease progression. This evidence concerns the gene CFL1 and Alzheimer disease.